The pharmaceutical industry is preparing for an accelerated pace of consolidation, with the number of mergers up 39 per cent since 2017¹. This year has already witnessed its first ‘super merger’ between two of the world’s largest pharmaceutical companies, Bristol-Myers and Celgene, valued at $74 billion.²

These cross appeals are filed by the Revenue and Assessee against order dated 12.03.2020 passed by the CIT(A)-1, Ahmedabad for the Assessment Year 2012-13.

2. The Revenue has raised the following grounds of appeal :-

ITA Nos.345 & 383/Ahd/2020 Assessment Years: 2012-13 "(1) The ld. CIT(A) has erred in facts and law in deleting the transfer pricing adjustment made in respect of Corporate guarantee fees of Rs.60,83,440/-

(2) The id. CIT(A) has erred in facts and law in deleting the interest disallowance of Rs.1,64,86,560/- u/s.36(1)(iii) of the Act.

These cross appeals are filed by the Revenue and Assessee against order dated 12.03.2020 passed by the CIT(A)-1, Ahmedabad for the Assessment Year 2012-13.

2. The Revenue has raised the following grounds of appeal :-

ITA Nos.345 & 383/Ahd/2020 Assessment Years: 2012-13 "(1) The ld. CIT(A) has erred in facts and law in deleting the transfer pricing adjustment made in respect of Corporate guarantee fees of Rs.60,83,440/-

(2) The id. CIT(A) has erred in facts and law in deleting the interest disallowance of Rs.1,64,86,560/- u/s.36(1)(iii) of the Act.

Of pharmaceutical products, health care products packaging theory , there are several aspects of the law we need to , inter alia: 1 , generate new theory of pharmaceutical products , not only to consider the psychological factors of...

[Prosper Africa] Prosper Africa's Tech for Trade Alliance (AT4T) is launching its latest pilot in Africa to field test a digital platform intended to bring visibility to Africa's drug supply chains, creating a more transparent, efficient, and safe commercial market for medications.

[MSF] Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, Sanofi, and all insulin manufacturers to take urgent action to increase access to diabetes treatment in low- and middle-income countries by immediately making insulin* pen injection devices available at US$1 (R17,81) per pen.

Do firms learn from their failed innovation attempts? Answering this question is important because failure is an integral part of exploratory learning. In this study, we explore whether and under what circumstances firms learn from their small failures in experimentation. Building on organizational learning literature, we examine the conditions under which prior failures influence firms' R&D output amount and quality. An empirical analysis of voluntary patent expirations (i.e., patents that firms give up by not paying renewal fees) in 97 pharmaceutical firms between 1980 and 2002 shows that the number, importance, and timing of small failures are associated with a decrease in R&D output (patent count) but an increase in the quality of the R&D output (forward citations to patents). Exploratory interviews suggest that the results are driven by a multi-level learning process from failures in pharmaceutical R&D. The findings contribute to the organizational learning literature by providing a nuanced view of learning from failures in experimentation.

Single-crystal X-ray diffraction analysis of small molecule active pharmaceutical ingredients is a key technique in the confirmation of molecular connectivity, including absolute stereochemistry, as well as the solid-state form. However, accessing single crystals suitable for X-ray diffraction analysis of an active pharmaceutical ingredient can be experimentally laborious, especially considering the potential for multiple solid-state forms (solvates, hydrates and polymorphs). In recent years, methods for the exploration of experimental crystallization space of small molecules have undergone a `step-change', resulting in new high-throughput techniques becoming available. Here, the application of high-throughput encapsulated nanodroplet crystallization to a series of six di­hydro­pyridines, calcium channel blockers used in the treatment of hypertension related diseases, is described. This approach allowed 288 individual crystallization experiments to be performed in parallel on each molecule, resulting in rapid access to crystals and subsequent crystal structures for all six di­hydro­pyridines, as well as revealing a new solvate polymorph of nifedipine (1,4-dioxane solvate) and the first known solvate of nimodipine (DMSO solvate). This work further demonstrates the power of modern high-throughput crystallization methods in the exploration of the solid-state landscape of active pharmaceutical ingredients to facilitate crystal form discovery and structural analysis by single-crystal X-ray diffraction.

The Drug-Releasing Contact Lens Contains a Broad-Spectrum Antibiotic

The Glint Drug-Releasing Contact Lens is a Platform Technology for Ocular Therapy

Veronique Michaud, PhD, is honored for her contributions as the president and co-founder of GalenusRx

Mamadou Tahirou Diallo, PharmD lends years of expertise to his work with Cardinal Health

Stephen Pham, PhD, recognized as Senior Vice President, Product Development at Avalyn Pharma Inc.

Paul Krauthauser is a pharmaceutical expert who excels in building high-functioning, high-performance teams

Tushar Mukherjee, PhD, lends years of expertise to drug delivery research and development

Heather D. Embree, MS, honored for her leadership and expertise in program management and drug development

Thomas John Karvosky is an expert in medical marijuana as a consultant dispensary pharmacist

Yue "Melody" Yin is an expert in clinical trial research in the pharmaceuticals and biotechnology industry

David is distinguished as a retired executive in pharmaceuticals and public health for more than 30 years

Jan M. Lundberg is a retired pharmaceutical researcher with over 30 years of professional success

Charu Yerneni, PhD, is a distinguished expert in pharmaceutical analysis with more than a decade of experience

Joan Buchanan channels years of expertise into her current role with CVS

Stephanie M. Chosa has been recognized for her success in leadership as a director of pharmacy

DeGaulle Cabinda, MD, serves as a global safety physician

Sheldon J. Rich lends years of expertise to his work with SJR Associates, LLC

Xian-Ming Zeng lends years of expertise to his work with Transpire Bio

Dr. Jennifer L. Foster is the director of global pharmacy operations at Celerion

Targeted therapy for lung cancer is based on personalized medicine approach

Personalized and targeted medicine for rare lung and other cancers

Conference Highlights Key Features of Successful Clinical Trial Management

Renadin Siagat has found success as a medical science liaison, entrepreneur, and humanitarian

Dennis Harris is a distinguished professional with decades of leadership experience in pharmaceuticals

Chardae Rodgers-Gamble, DBA, is a seasoned expert and founder of CR Clinical and Jackson Taylor Therapeutics

Yacine M. Amrani, PharmD, PhD, MBA, is honored for his experience as a research scientist and healthcare strategist, leading to his current work as a senior director of business development at PTC Therapeutics Inc.

Matthew A. Dixon is an expert in international trade compliance for medical devices and pharmaceutical products

Investigation to initiate in Q2 2023

The Glint Drug-Releasing Contact Lens Replaces Standard Eye Drops

The first Glint product, MoxiLens™, is an antibiotic releasing contact lens.

Unveiling My Compounding Pharmacy's Innovative Pharmaceutical Medicine Range

Charting the Future of Healthcare with Dr. Nabil Alhakamy: Transformative Strategies and Global Ambitions

Zhonggai "Kevin" Li, PhD, is lauded as a senior director of biostatistics at Sumitomo Pharma Oncology

Derek James Evans excels in sales and marketing as a regional business director at Axsome Therapeutics Inc.

Mario DiPaola is noted for his pioneering cancer treatments at Therabene Inc

Katherine Hester, MD, PhD, RAC, is noted for her success in clinical research and regulatory submissions

Abe Germansderfer is a seasoned expert and leader in biotechnology manufacturing, quality, process development, statistics, regulatory affairs and regulatory submissions

World Health Organization Launches Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector at University of TorontoToronto, ON – The University of Toronto and the World Health Organization are proud to launch the WHO Collaborating Centre for Governance, Accountability and Transparency for the Pharmaceutical Sector with a policy workshop and celebration at the Leslie […]

The global pharmaceutical packaging market is set to grow over 5% year-over-year in 2019, and bottles will remain highly sought after, followed by blisters, vials and ampoules.

Drug-producing industries are expected to continue to operate at normal or near normal capacities despite the COVID-19 pandemic.

The pharmaceutical industry is undergoing a tremendous packaging revolution, paving way for the future development of intelligent solutions. One such breakthrough achieved in this space is the blister packaging.